Every SEC Form 3/4/5 on record for this filer (CIK 1663758) — 5 issuers, 110 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | EVP Commercial | 2018-02-12 → 2025-12-11 | 61 | −$31M |
| SCYX | SCYNEXIS INC | Director · lapsed | 2017-01-27 → 2018-07-03 | 10 | — |
| CTMX | CytomX Therapeutics, Inc. | Director · lapsed | 2017-03-31 → 2017-06-22 | 3 | — |
| AXON | AXON ENTERPRISE, INC. | Principal Operating Officer · lapsed | 2017-04-11 → 2017-04-11 | 2 | — |
| MDVN | MEDIVATION, INC. | Chief Operating Officer · lapsed | 2016-02-04 → 2016-09-30 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| REGN | 2024-11-01 | Sell | 1,000 | $844.61 | $844,610 | 12,931 |
| REGN | 2024-10-01 | Sell | 1,000 | $1,054.06 | $1M | 12,931 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
